Pfizer-BioNTech files for U.S. approval of COVID-19 vaccine
Reuters, 08 May 2021
Pfizer and German partner BioNTech have filed for a full U.S. approval for their COVID-19 vaccine, which is now authorized only for emergency use, the drugmakers said on Friday.
Reuters brings you the latest business, finance and breaking news video from around the globe. Our reputation for accuracy and impartiality is unparalleled.
Get the latest news on: http://reuters.com/
Follow Reuters on Facebook: https://www.facebook.com/Reuters
Follow Reuters on Twitter: https://twitter.com/Reuters
Follow Reuters on Instagram: https://www.instagram.com/reuters/?hl=en